The data presented above suggest that the detection of increased galectin-3 levels in the serum of certain patients with cancer may reflect biological aspects of tumor behavior associated with enzymatic activity of certain enzymes (PSA, MMPs, c-Abl, PTEN). This evidence concerns the gene PTEN and cancer.